We are live on
!
Find out more
Cerity Partners Portfolio holdings
AUM
$70.8B
1-Year Est. Return
21.68%
This Fund
S&P 500
This Quarter
Est. Return
+5.11%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
–
AUM
$4.21B
AUM Growth
+$1.09B
(+35%)
Cap. Flow
+$955M
Cap. Flow
% of AUM
22.68%
Top 10 Holdings %
Top 10 Hldgs %
34.29%
Holding
765
New
125
Increased
259
Reduced
265
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$110M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$47.6M |
| 3 |
Apple
AAPL
|
+$45.5M |
| 4 |
Microsoft
MSFT
|
+$37.2M |
| 5 |
Amazon
AMZN
|
+$33.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMD
Cantel Medical Corporation
CMD
|
+$15.9M |
| 2 |
Caterpillar
CAT
|
+$8.11M |
| 3 |
Golub Capital BDC
GBDC
|
+$7.53M |
| 4 |
Intel
INTC
|
+$6.76M |
| 5 |
iShares Biotechnology ETF
IBB
|
+$6.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.98% |
| 2 | Industrials | 11.87% |
| 3 | Financials | 10.81% |
| 4 | Healthcare | 9.53% |
| 5 | Consumer Discretionary | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
iShares Russell 2000 ETF
IWM
$80.9B
| $30M | 0.71% |
135,962
-1,113
| -0.8% | -$243K |
|
27
Procter & Gamble
PG
$343B
| $29.9M | 0.71% |
220,486
+86,179
| +64% | +$11.2M |
|
28
SPDR Gold Trust
GLD
$131B
| $28.4M | 0.67% |
177,290
+105,377
| +147% | +$17.7M |
|
29
iShares Core S&P 500 ETF
IVV
$876B
| $28.3M | 0.67% |
71,140
+3,696
| +5% | +$1.43M |
|
30
UnitedHealth
UNH
$382B
| $27.7M | 0.66% |
74,319
+34,333
| +86% | +$11.9M |
|
31
Danaher
DHR
$135B
| $27.1M | 0.64% |
135,940
+56,627
| +71% | +$11.5M |
|
32
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
| $26.8M | 0.64% |
416,777
+23,218
| +6% | +$1.53M |
|
33
Alphabet (Google) Class A
GOOGL
$3.91T
| $26.8M | 0.64% |
259,680
-2,480
| -0.9% | -$245K |
|
34
Vanguard Value ETF
VTV
$189B
| $26.7M | 0.63% |
203,056
+13,612
| +7% | +$1.71M |
|
35
Alibaba
BABA
$269B
| $26.1M | 0.62% |
115,215
+11,023
| +11% | +$2.71M |
|
36
Cisco
CSCO
$450B
| $24.9M | 0.59% |
481,631
-6,136
| -1% | -$288K |
|
37
Merck
MRK
$324B
| $24.8M | 0.59% |
336,656
+204,622
| +155% | +$15.1M |
|
38
AbbVie
ABBV
$458B
| $24.5M | 0.58% |
226,776
+107,276
| +90% | +$11.5M |
|
39
Adobe
ADBE
$89.5B
| $23.7M | 0.56% |
49,792
+22,624
| +83% | +$10.6M |
|
40
PepsiCo
PEP
$186B
| $23.7M | 0.56% |
167,300
+37,404
| +29% | +$5.13M |
|
41
Qualcomm
QCOM
$176B
| $22.5M | 0.53% |
169,769
+15,306
| +10% | +$2.21M |
|
42
Union Pacific
UNP
$183B
| $22.2M | 0.53% |
100,690
+74,365
| +282% | +$15.6M |
|
43
Accenture
ACN
$89.9B
| $21.3M | 0.51% |
77,169
+46,411
| +151% | +$12M |
|
|
44
Golub Capital BDC
GBDC
$3.33B
| $20.2M | 0.48% |
1,382,921
-512,383
| -27% | -$7.53M |
|
45
Starbucks
SBUX
$118B
| $19.9M | 0.47% |
182,469
+66,876
| +58% | +$7.02M |
|
46
iShares Intermediate Government/Credit Bond ETF
GVI
$3.72B
| $19.5M | 0.46% |
169,590
+7,644
| +5% | +$889K |
|
47
Boeing
BA
$165B
| $19.1M | 0.45% |
74,909
+51,699
| +223% | +$11.5M |
|
48
TJX Companies
TJX
$170B
| $18.7M | 0.44% |
282,463
+167,565
| +146% | +$11.2M |
|
49
Comcast
CMCSA
$79.1B
| $18.7M | 0.44% |
345,164
+237,296
| +220% | +$12.5M |
|
50
Vanguard Growth ETF
VUG
$216B
| $18.3M | 0.44% |
428,130
+137,562
| +47% | +$5.89M |
|
Similar funds
Cerity Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Cerity Partners held 765 positions worth $4.21B, up 35% from $3.12B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Cerity Partners deployed $955M of net new capital in Q1 2021, opening 125 new positions and adding to 259 existing holdings. Its largest new stake was Allogene Therapeutics: 401,602 shares worth $14.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Caterpillar, an estimated $8.11M trimmed.
- Cerity Partners's largest Q1 2021 buy was Allogene Therapeutics: 401,602 shares worth $14.2M.
- Cerity Partners added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $110M increase.
- Cerity Partners's biggest Q1 2021 reduction was Caterpillar, cutting an estimated $8.11M.
- Cerity Partners fully exited Cantel Medical Corporation in Q1 2021, selling an estimated $15.9M.
- Cerity Partners's ten largest holdings make up 34% of its $4.21B portfolio in Q1 2021.
- Cerity Partners opened 125 new positions and closed 72 in Q1 2021.
- Cerity Partners's portfolio value rose 35% quarter-over-quarter to $4.21B.
Based on Cerity Partners's 13F filing for Q1 2021, filed 12 May 2021.